Clayton B. Barlow

Cancer Therapeutics, Inc. is a biotechnology business incubator, with a specific emphasis on disruptive treatments and nanotechnology. It seeks out disruptive cancer research and technology opportunities to invest in, develop and commercialize. It offers therapies, treatments, and pharmaceuticals targeted at more efficiently and effectively attacking cancer. Its development of these life-changing therapies for cancer treatment is achieved through an evolving set of intellectual properties and patents derived from the exploitation of calcium phosphate nanoparticles for therapeutic and diagnostic applications. The company was founded on May 1, 1991 and is headquartered in South Jordan, UT.

Founded in 1998, iBAHN is the only global provider of digital information / entertainment and Internet solutions for the hospitality and meeting industries. Monthly, more than 1.8 million travelers and meeting attendees rely on iBAHN to increase productivity with secure high-speed Internet access options in nearly 3,000 hotels, conference centers and meeting spaces in 41 countries worldwide. iBAHN's digital entertainment and information services feature leading programming in the Americas, Europe, Asia, Australia and India. Operating one of the largest MPLS networks in the industry, the company provides technology solutions to more than 50,000 events annually, ranging from small group meetings to major industry conferences, while serving more than 40% of Fortune 100 corporations. iBAHN is headquartered in Salt Lake City, Utah with additional local offices around the world. It is the only global provider of digital entertainment and Internet solutions for the hospitality and meeting industries. Monthly, more than 1.7 million travelers and meeting attendees rely on iBAHN to increase productivity with secure high-speed internet access options in more than 2,500 hotels, conference centers and meeting spaces in 34 countries worldwide across six continents. iBAHN's digital entertainment offering, ETVi, offers hotel guests leading digital video and entertainment services.

Cancer Therapeutics, Inc. is a biotechnology business incubator, with a specific emphasis on disruptive treatments and nanotechnology. It seeks out disruptive cancer research and technology opportunities to invest in, develop and commercialize. It offers therapies, treatments, and pharmaceuticals targeted at more efficiently and effectively attacking cancer. Its development of these life-changing therapies for cancer treatment is achieved through an evolving set of intellectual properties and patents derived from the exploitation of calcium phosphate nanoparticles for therapeutic and diagnostic applications. The company was founded on May 1, 1991 and is headquartered in South Jordan, UT.